The luminal cluster predominantly harboring luminal breast tumors (ER/PR+, HER2+/−) was associated with strong overexpression of the estrogen receptor (ESR1) and the ERBB2 oncogene (Figure 1C). Here, ESR1 is linked to breast neoplasm.